Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 52

Sort by

Sort Order Select

Journal Articles

Animal Models Demonstrate a Critical Role of Factor VIII in Par4- and Platelet-Mediated Pathology

Michelle Castillo, BS, Quihui Yang, MD PhD, Dosia McKinney, Qizhen Shi, MD PhD, Rashmi Sood, PhD

Blood (2019) 134 (Supplement_1): 1057.

https://doi.org/10.1182/blood-2019-123290

Published: 2019

Journal Articles

Comparison of Minimal Residual Disease Detection in Autografts of Patients with Multiple Myeloma between 8-Color Multiparameter Flow Cytometry (EuroFlow) and Next-Generation Sequencing

Hiroyuki Takamatsu, MDPhD, Naoki Takezako, MD PhD, Rachel K Wee, Takeshi Yoroidaka, MD, Takeshi Yamashita, MD, Ryoichi Murata, MD, Kosei Matsue, MD PhD, Shinji Nakao, MD PhD

Blood (2018) 132 (Supplement 1): 258.

https://doi.org/10.1182/blood-2018-99-111250

Published: 2018

Journal Articles

Integrin Alphav-beta3 on Podocytes Orchestrates Coagulation Protease Signaling through Protease-Activated Receptors

Madhusudhan Thati, PhD, Sanchita Ghosh, MS, Hongjie Wang, MD PhD, Wolfram Ruf, MD, Berend H. Isermann, MD

Blood (2018) 132 (Supplement 1): 137.

https://doi.org/10.1182/blood-2018-99-114566

Published: 2018

Journal Articles

Extravascular coagulation in hematopoietic stem and progenitor cell regulation

T. Son Nguyen, Tsvee Lapidot, Wolfram Ruf

Blood (2018) 132 (2): 123–131.

https://doi.org/10.1182/blood-2017-12-768986

Published: 2018

Journal Articles

Cytoprotective activated protein C averts Nlrp3 inflammasome–induced ischemia-reperfusion injury via mTORC1 inhibition

Sumra Nazir, Ihsan Gadi, Moh’d Mohanad Al-Dabet, Ahmed Elwakiel, Shrey Kohli, Sanchita Ghosh, Jayakumar Manoharan, Satish Ranjan, Fabian Bock, Ruediger C. Braun-Dullaeus, Charles T. Esmon, Tobias B. Huber, Eric Camerer, Chris Dockendorff, John H. Griffin, Berend Isermann, Khurrum Shahzad

Blood (2017) 130 (24): 2664–2677.

https://doi.org/10.1182/blood-2017-05-782102

Published: 2017

Includes: Supplemental data

Journal Articles

On PAR with aPC to target inflammasomes

Steven R. Lentz

Blood (2017) 130 (24): 2579–2581.

https://doi.org/10.1182/blood-2017-09-806307

Published: 2017

Journal Articles

Signal integration at the PI3K-p85-XBP1 hub endows coagulation protease activated protein C with insulin-like function

Blood (2017) 130 (12): 1445–1455.

https://doi.org/10.1182/blood-2017-02-767921

Published: 2017

Includes: Supplemental data

Journal Articles

Diabetic kidney disease: as easy as aPC?

James D. McFadyen, Mark E. Cooper

Blood (2017) 130 (12): 1390–1391.

https://doi.org/10.1182/blood-2017-08-798314

Published: 2017

Journal Articles

Sustained Overall Survival Benefit with Lenalidomide Plus Dexamethasone Versus No Treatment in Patients with Smoldering Myeloma at High Risk of Progression to Myeloma: Long Term Analysis

Maria-Victoria Mateos, MD PhD, Miguel-T Hernandez, Pilar Giraldo, MD PhD, Javier De La Rubia, Felipe De Arriba, Lucia Lopez-Corral, Laura Rosiñol, Bruno Paiva, PhD, Luis Palomera, MD PhD, Joan Bargay, MD, Albert Oriol, Felipe Prosper, MD, Javier Lopez, Sr., MD PhD, Jose-María Arguiñano, Nuria Quintana, Jose Luis Garcia, Joan Bladé, Juan José Lahuerta, MD PhD, Jesus San Miguel, MD PhD

Blood (2016) 128 (22): 3308.

https://doi.org/10.1182/blood.V128.22.3308.3308

Published: 2016

Journal Articles

Circulating Activated Protein C in Thrombophilia Carriers

Thijs E van Mens, MD MBA, Joost C.M. Meijers, PhD Professor, Saskia Middeldorp, MD PhD Professor of MDcine

Blood (2016) 128 (22): 4948.

https://doi.org/10.1182/blood.V128.22.4948.4948

Published: 2016

Journal Articles

EPCR Guides Hematopoietic Stem Cells Homing to the Bone Marrow Independently of Niche Clearance

Blood (2016) 128 (22): 4538.

https://doi.org/10.1182/blood.V128.22.4538.4538

Published: 2016

Journal Articles

Coagulation Factor V Mediates Inhibition of Tissue Factor Signaling By Activated Protein C

Hartmut Weiler, Hai-Po Liang, PhD, Edward J Kerschen, PhD, Alireza Rezaie, PhD, Jose A. Fernandez, MD PhD, Rodney M. Camire, PhD, Wolfram Ruf, MD, John H. Griffin, PhD, Raffaele Toso, PhD

Blood (2015) 126 (23): 216.

https://doi.org/10.1182/blood.V126.23.216.216

Published: 2015

Journal Articles

EPCR/PAR1 Signaling Navigates Long-Term Repopulating Hematopoietic Stem Cell Bone Marrow Homing to Thrombomodulin-Enriched Blood Vessels

Shiri Gur Cohen, PhD, Tomer Itkin, PhD, Sagarika Chakrabarty, PhD, Claudine Graf, MD, Orit Kollet, PhD, Karin Golan, PhD, Alexander Kalinkovich, MDPhD, Charles T. Esmon, PhD, Wolfram Ruf, MD, Irit Sagi, PhD, Ayelet Erez, PhD, Tsvee Lapidot, PhD

Blood (2015) 126 (23): 33.

https://doi.org/10.1182/blood.V126.23.33.33

Published: 2015

Journal Articles

Plasma Constitutive Serum Amyloid A4 Is Procoagulant and Is Elevated in Venous Thrombosis Patients

John H. Griffin, PhD, Jose A. Fernandez, MD PhD, Ranjeet Kumar Sinha, PhD MSc, Darlene J. Elias, MD, Hiroshi Deguchi, MD PhD

Blood (2015) 126 (23): 3486.

https://doi.org/10.1182/blood.V126.23.3486.3486

Published: 2015

Journal Articles

Genetic Absence of Thrombin Receptor Par4 Overcomes the Obligate Requirement of EPCR in Mouse Placenta

Michelle M Storage, BS, Jianzhong An, MD, Helena Liang, Qiuhui Yang, MD PhD, Mark Zogg, BS, Min Zhan, MS, Hartmut Weiler, Rashmi Sood, PhD

Blood (2015) 126 (23): 425.

https://doi.org/10.1182/blood.V126.23.425.425

Published: 2015

Journal Articles

Coagulation factor V mediates inhibition of tissue factor signaling by activated protein C in mice

Hai Po H. Liang, Edward J. Kerschen, Sreemanti Basu, Irene Hernandez, Mark Zogg, Shuang Jia, Martin J. Hessner, Raffaella Toso, Alireza R. Rezaie, José A. Fernández, Rodney M. Camire, Wolfram Ruf, John H. Griffin, Hartmut Weiler

Blood (2015) 126 (21): 2415–2423.

https://doi.org/10.1182/blood-2015-05-644401

Published: 2015

Includes: Supplemental data

Journal Articles

Resistance to Thrombomodulin but Not to Activated Protein C in Cirrhotic Patients

Thomas Sinegre, PharmD, Armand Abergel, MD PhD, Cedric Duron, MD, Marc G Berger, MD PhD Professor, Aurélien Lebreton, MD PhD

Blood (2014) 124 (21): 2839.

https://doi.org/10.1182/blood.V124.21.2839.2839

Published: 2014

Journal Articles

Long Term Follow-up on the Tretament of High Risk Smoldering Myeloma with Lenalidomide Plus Low Dose Dex (Rd) (phase III spanish trial): Persistent Benefit in Overall Survival

Maria-Victoria Mateos, MD PhD, Miguel T Hernandez, MD, Pilar Giraldo, MD PhD, Javier De La Rubia, Felipe de Arriba, Lucía López-Corral, MD PhD, Laura Rosiñol, MD PhD, Bruno Paiva, PhD, Luis Palomera, Joan Bargay, MD, Albert Oriol, MD, Felipe Prosper, MD, Javier López, Eduardo Olavarría, MD, Nuria Quintana, Jose Luis García, Joan Blade, Juan José Lahuerta, MD PhD, Jesus F. San Miguel

Blood (2014) 124 (21): 3465.

https://doi.org/10.1182/blood.V124.21.3465.3465

Published: 2014

Journal Articles

A Proposed Role for Platelet Factor 4 in Histone Pathobiology in Sepsis

M. Anna Kowalska, PhD, Guohua Zhao, PhD, Ian Johnston, BS, Elsa Treffeisen, BA, Fatoumata Diarra, Sriram Krishnaswamy, PhD, Mortimer Poncz, MD

Blood (2014) 124 (21): 98.

https://doi.org/10.1182/blood.V124.21.98.98

Published: 2014

Journal Articles

Site-Directed Pegylation of BDD FVIII (BAY 94-9027) Does Not Alter the Ability of the Molecule to Generate Thrombin, Activate Factor X or Become Inactivated By Activated Protein C

Subramanian Yegneswaran, PhD, Xiaoqiao Jiang, BS, Pooja Yesantharao, Ji-Yun Kim, PhD, Lilley Leong, PhD MS, Derek S Sim, PhD, Chandra Patel, PhD, Katalin Zsofia Kauser, PhD MD DSc

Blood (2014) 124 (21): 1492.

https://doi.org/10.1182/blood.V124.21.1492.1492

Published: 2014

NARROW

Animal Models Demonstrate a Critical Role of Factor VIII in Par4- and Platelet-Mediated Pathology

Comparison of Minimal Residual Disease Detection in Autografts of Patients with Multiple Myeloma between 8-Color Multiparameter Flow Cytometry (EuroFlow) and Next-Generation Sequencing

Integrin Alphav-beta3 on Podocytes Orchestrates Coagulation Protease Signaling through Protease-Activated Receptors

Extravascular coagulation in hematopoietic stem and progenitor cell regulation

Cytoprotective activated protein C averts Nlrp3 inflammasome–induced ischemia-reperfusion injury via mTORC1 inhibition

On PAR with aPC to target inflammasomes

Signal integration at the PI3K-p85-XBP1 hub endows coagulation protease activated protein C with insulin-like function

Diabetic kidney disease: as easy as aPC?

Sustained Overall Survival Benefit with Lenalidomide Plus Dexamethasone Versus No Treatment in Patients with Smoldering Myeloma at High Risk of Progression to Myeloma: Long Term Analysis

Circulating Activated Protein C in Thrombophilia Carriers

EPCR Guides Hematopoietic Stem Cells Homing to the Bone Marrow Independently of Niche Clearance

Coagulation Factor V Mediates Inhibition of Tissue Factor Signaling By Activated Protein C

EPCR/PAR1 Signaling Navigates Long-Term Repopulating Hematopoietic Stem Cell Bone Marrow Homing to Thrombomodulin-Enriched Blood Vessels

Plasma Constitutive Serum Amyloid A4 Is Procoagulant and Is Elevated in Venous Thrombosis Patients

Genetic Absence of Thrombin Receptor Par4 Overcomes the Obligate Requirement of EPCR in Mouse Placenta

Coagulation factor V mediates inhibition of tissue factor signaling by activated protein C in mice

Resistance to Thrombomodulin but Not to Activated Protein C in Cirrhotic Patients

Long Term Follow-up on the Tretament of High Risk Smoldering Myeloma with Lenalidomide Plus Low Dose Dex (Rd) (phase III spanish trial): Persistent Benefit in Overall Survival

A Proposed Role for Platelet Factor 4 in Histone Pathobiology in Sepsis

Site-Directed Pegylation of BDD FVIII (BAY 94-9027) Does Not Alter the Ability of the Molecule to Generate Thrombin, Activate Factor X or Become Inactivated By Activated Protein C

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only